Evidence map›Paper›PMID 42247468›Full record

ArticlePLoS pathogens2026

HIV-1 BG505 SOSIP immunization induced B cell expansion targeting the 465-glycan hole, with neutralizing antibodies exhibiting distinct binding modes and mechanisms of virus inhibition.

August Myers, Monika Chandravanshi, Leanne S Whitmore, Brendan F Kohrn, Amina Negash, Dung N Nguyen, Pooja Ralli-Jain, Kendra Cruickshank, Amit A Upadhyay, Tysheena Charles and 11 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

August MyersDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.
Monika ChandravanshiInfectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.
Leanne S WhitmoreDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.
Brendan F KohrnDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.
Amina NegashDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.
Dung N NguyenInfectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.
Pooja Ralli-JainDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.
Kendra CruickshankDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.
Amit A UpadhyayDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America.
Tysheena CharlesEmory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
Christopher T EdwardsDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America.
Eric HunterDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America.
Rama R AmaraEmory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
Marek K KorzeniowskiInfectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.
Ling NiuInfectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.
Edwin PozharskiInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, United States of America.
William D TolbertInfectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.
Steven E BosingerDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America.
Scott R KennedyDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.
Marzena PazgierInfectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.
Cynthia A DerdeynDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0002-1220-513X

Funding

Using DNA/MVA/protein immunization of rhesus macaques to investigate how the background of the HIV-1 envelope and nature of the protein boost shape the genetic and functional antibody landscape.R01AI128837 · NIAID · EMORY UNIVERSITY · PI BOSINGER, STEVEN EDWARD, DERDEYN, CYNTHIA ANN · 2017 to 2021
$5.9M
Tracking the evolutionary trajectory of neutralizing antibodies following BG505 SOSIP immunizationR01AI174979 · NIAID · UNIVERSITY OF WASHINGTON · PI DERDEYN, CYNTHIA ANN · 2023 to 2025
$3.9M
NIAID NIH HHS R01 AI128837NIAID NIH HHS R01 AI174979
6 · The paper itself

Abstract

High serum neutralization following BG505 SOSIP.664 envelope trimer immunization was associated with protection against BG505.SHIV challenge in rhesus macaques in a previous study. In an animal that developed high titer, durable neutralization against a glycan hole on envelope gp120, high throughput, longitudinal, antigen-specific B cell receptor sequencing was conducted. This analysis of more than 4,700 antigen-specific B cells revealed marked intra-clonal expansion and divergence from germline, including three abundant clonotypes that produced autologous neutralizing monoclonal antibodies. Monoclonal antibodies from the neutralizing clonotypes and two other expanded non-neutralizing clonotypes targeted epitopes in the same glycan hole, with neutralizers also demonstrating different capacities to obstruct CD4 binding. Cryo-electron microscopy structures of four neutralizing monoclonal antibodies revealed that they bound to glycan hole epitopes using distinct binding modes. One neutralizing antibody displaced a glycan in the loop V5 upon binding and its footprint includes the CD4 binding loop. The findings provide insight into how antibody recognition of a prominent glycan hole could facilitate different mechanisms of neutralization while underscoring how intra-clonal expansion and maturation with repeated BG505 SOSIP.664 immunization drove high serum neutralization.

Indexed as

AIDS VaccinesAntibodies, NeutralizingB-Lymphocytesenv Gene Products, Human Immunodeficiency VirusHIV-1HIV AntibodiesHIV InfectionsPolysaccharidesAnimalsAntibodies, MonoclonalEpitopesImmunizationMacaca mulattaAIDS VaccinesAntibodies, MonoclonalAntibodies, Neutralizingenv Gene Products, Human Immunodeficiency VirusEpitopesHIV AntibodiesPolysaccharides

Identifiers

PMID42247468
PMCPMC13262937

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.